Bristol Medical School

Age and gender impacts effectiveness of new gene therapy treatments for eye diseases, new study finds

Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research has found. The University of Bristol-led study, published in Molecular Therapy, reveal how age and gender affects inflammation caused by gene therapy treatments and could cause damage to the eye. The findings could help improve the therapy’s effectiveness for eye conditions and highlights the need for personalised treatment to reduce risk and ensure a better outcome for all patients.

Study reveals stark ethnic and social disparities in stillbirths within individual hospitals and healthcare trusts in England

Stillbirth rates are known to be higher for Black and Asian women than for white women, and those living in the most deprived areas are more at risk than those in the least deprived areas. Now a new University of Bristol-led study published in the Journal of Obstetrics & Gynaecology (BJOG) today [16 May] reveals that these disparities exist even within individual hospitals and NHS Trusts.

Bristol part of largest global study on impact of COVID-19 across 129 countries

The COH-FIT project is currently the largest survey worldwide on the health impact of COVID-19 and is endorsed by the World Psychiatric Association. The study aims to identify risk and protective factors for physical and mental health problems and to guide strategies for remedying these problems. The COH-FIT project involves 200 researchers from 35 countries, including Bristol, aims to help scientists understand how different countries have been affected by the pandemic.